Athelas B&P

Athelas is a healthcare technology company that specializes in remote patient monitoring (RPM) and rapid diagnostic hardware. The company's flagship product, the Athelas One, is an FDA-cleared device that allows for point-of-care white blood cell count and differential monitoring, specifically designed for patients on medications like Clozapine. Beyond diagnostics, Athelas provides a comprehensive suite of software tools for revenue cycle management and patient engagement. In 2023, Athelas merged with Commure to create a unified health technology platform focused on automating clinical workflows and improving patient outcomes.